<h4>Background</h4>Unlike mouse models of congenital toxoplasmosis, pregnant sheep models provide the opportunity to evaluate treatment strategies that more closely resemble clinical practice in pregnant women, including chemotherapeutic interventions initiated after specific IgM seroconversion. The gene discussed is CD40LG; the disease is congenital toxoplasmosis.